P06213 (INSR_HUMAN) Homo sapiens (Human)
Insulin receptor UniProtKBInterProSTRINGInteractive Modelling
1382 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
71 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
human insulin receptor ectodomain bound by 4 insulin |
Heteromer P01308; | |||||
Assess | ||||||
tentative model of the human insulin receptor ectodomain bound by three insulin |
Heteromer P01308; | |||||
Assess | ||||||
Structure of the human insulin receptor ectodomain, IRDeltabeta construct, in complex with four Fab… |
Heteromer A2P1G9; P01837; P01865; U5LP42; | 6×NAG; 2×NAG; 2×NAG; 4×NAG; 6×NAG; | ||||
Assess | ||||||
The insulin receptor ectodomain in complex with three venom hybrid insulin molecules - asymmetric c… |
Heteromer P01308; | |||||
Assess | ||||||
The insulin receptor ectodomain in complex with four venom hybrid insulins - symmetric conformation |
Heteromer P01308; | 20×NAG; | ||||
Assess | ||||||
Cryo-EM structure of full-length insulin receptor bound to 4 insulin. 3D refinement was focused on … |
Heteromer A6XGL2; | |||||
Assess | ||||||
Insulin receptor ectodomain dimer complexed with two IRPA-3 partial agonists |
Heteromer P01308; | |||||
Assess | ||||||
Leg region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type 1 insulin-… |
Heteromer P08069; | 2×NAG; 1×NAG; 5×NAG; | ||||
Assess | ||||||
Low resolution Cryo-EM structure of full-length insulin receptor bound to 3 insulin, conf 1 |
Heteromer P01308; | |||||
Assess | ||||||
Low resolution Cryo-EM structure of full-length insulin receptor bound to 3 insulin with visible dd… |
Heteromer P01308; | |||||
Assess | ||||||
Low resolution Cryo-EM structure of the full-length insulin receptor bound to 3 insulin, conf 2 |
Heteromer P01308; | |||||
Assess | ||||||
human insulin receptor bound with A62 DNA aptamer and insulin |
Heteromer F8WCM5; P01308; | |||||
Assess | ||||||
Low resolution Cryo-EM structure of the full-length insulin receptor bound to 2 insulin, conf 3 |
Heteromer P01308; | |||||
Assess | ||||||
human insulin receptor bound with A43 DNA aptamer and insulin |
Heteromer F8WCM5; P01308; | |||||
Assess | ||||||
human insulin receptor bound with two insulin molecules |
Heteromer F8WCM5; P01308; | |||||
Assess | ||||||
Cryo-EM structure of short form insulin receptor (IR-A) with four IGF2 bound, symmetric conformatio… |
Heteromer P01344; | |||||
Assess | ||||||
Cryo-EM structure of long form insulin receptor (IR-B) with four IGF2 bound, symmetric conformation. |
Heteromer P01344; | |||||
Assess | ||||||
Cryo-EM structure of short form insulin receptor (IR-A) with three IGF2 bound, asymmetric conformat… |
Heteromer P01344; | |||||
Assess | ||||||
Cryo-EM structure of long form insulin receptor (IR-B) with three IGF2 bound, asymmetric conformati… |
Heteromer P01344; | |||||
Assess | ||||||
Cryo-EM Structure for the Ectodomain of the Full-length Human Insulin Receptor in Complex with 2 In… |
Heteromer P01308; | |||||
Assess | ||||||
Cryo-EM Structure for the Ectodomain of the Full-length Human Insulin Receptor in Complex with 1 In… |
Heteromer P01308; | |||||
Assess | ||||||
Insulin receptor ectodomain dimer complexed with two IRPA-9 partial agonists |
Heteromer P01308; | 4×NAG; 2×NAG; 2×NAG; 2×NAG; 4×NAG; | ||||
Assess | ||||||
Insulin Receptor ectodomain in complex with one insulin molecule |
Heteromer P01308; P01318; | |||||
Assess | ||||||
Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry |
Heteromer P01308; P01318; | 4×NAG; 2×NAG; 2×NAG; 2×NAG; 4×NAG; | ||||
Assess | ||||||
Leucine-zippered human insulin receptor ectodomain with single bound insulin - "upper" membrane-dis… |
Heteromer P01308; | 1×NAG; 9×NAG; | ||||
Assess | ||||||
The insulin receptor ectodomain in complex with a venom hybrid insulin analog - "head" region |
Heteromer P01308; | 2×NAG; 12×NAG; | ||||
Assess | ||||||
Head region of insulin receptor ectodomain (A-isoform) bound to the non-insulin agonist IM462 |
Heteromer P01308; | 1×NAG; 6×NAG; | ||||
Assess | ||||||
human insulin receptor bound with A62 DNA aptamer and insulin - locally refined |
Heteromer F8WCM5; P01308; | |||||
Assess | ||||||
Insulin Receptor ectodomain in complex with two insulin molecules |
Heteromer P01308; P01318; | 4×NAG; 2×NAG; 2×NAG; 2×NAG; 4×NAG; | ||||
Assess | ||||||
Cryo-EM structure of full-length insulin receptor bound to 4 insulin. 3D refinement was focused on … |
Heteromer A6XGL2; | |||||
Assess | ||||||
Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 |
Heteromer P01308; | 1×NAG; 2×NAG; 2×NAG; | ||||
Assess | ||||||
Con-Ins G1 in complex with the human insulin microreceptor in turn in complex with Fv 83-7 |
Heteromer A0A0B5A8Q2; A0A0B5AC95; | 1×NAG; 1×NAG; 3×NAG; 3×SO4; | ||||
Assess | ||||||
Insulin in complex with Site 1 of the human insulin receptor |
Heteromer P01308; | 1×NAG; 1×NAG; 3×NAG; | ||||
Assess | ||||||
Insulin Receptor L1-CR plus alphaCT fragment in co-complex with Fv 83-7 and single-chain insulin SC… |
Heteromer P01308; | 2×NAG; 1×NAG; 1×NAG; 1×SO4; 1×GOL; 1×NAG; | ||||
Assess | ||||||
Cryo-EM Structure for the Insulin Binding Region in the Ectodomain of the Full-length Human Insulin… |
Heteromer P01308; | |||||
Assess | ||||||
Insulin receptor ectodomain construct comprising domains L1-CR in complex with human insulin, Alpha… |
Heteromer P01308; | 1×NAG; 1×NAG; 3×NAG; | ||||
Assess | ||||||
Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insuli… |
Heteromer P01308; | 1×NAG; 1×NAG; 2×NAG; | ||||
Assess | ||||||
Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insuli… |
Heteromer P01308; | 1×NAG; 1×NAG; 2×NAG; | ||||
Assess | ||||||
Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in c… |
Heteromer P01317; | 4×NAG; 2×NAG; | ||||
Assess | ||||||
Head region of insulin receptor ectodomain (A-isoform) bound to the non-insulin agonist IM459 |
Heteromer | |||||
Assess | ||||||
Head region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type 1 insulin… |
Heteromer P05019; P08069; | 2×NAG; 1×NAG; 1×BMA; 7×NAG; | ||||
Assess | ||||||
Insulin-like growth factor I in complex with site 1 of a hybrid insulin receptor / Type 1 insulin-l… |
Heteromer P05019; P08069; | 1×NAG; 1×NAG; 1×SO4; 4×NAG; | ||||
Assess | ||||||
Structure of the endoglycosidase-H treated L1-CR domains of the human insulin receptor in complex w… |
Heteromer P15127; | 1×NAG; 3×NAG; 2×SO4; | ||||
Assess | ||||||
Crystal structure of the Grb14 BPS region in complex with the insulin receptor tyrosine kinase |
Heteromer Q14449; | 2×CA; | ||||
Assess | ||||||
Phosphorylated insulin receptor tyrosine kinase in complex with (4-{[5-carbamoyl-4-(3-methylanilino… |
Heteromer P35568; | 1×S91; | ||||
Assess | ||||||
Human insulin receptor domains L1-CR in complex with peptide S519C16 and 83-7 Fv |
Heteromer | 1×NAG; 1×NAG; 1×NAG; 2×NAG; | ||||
Assess | ||||||
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide |
Heteromer P81122; | |||||
Assess | ||||||
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB phosphopeptide |
Heteromer P81122; | |||||
Assess | ||||||
Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide and ATP |
Heteromer P81122; | 1×MG; 1×ATP; | ||||
Assess | ||||||
Crystal structure of a complex between PTP1B and the insulin receptor tyrosine kinase |
Heteromer P18031; | 10×SO4; | ||||
Assess | ||||||
Crystal Structure of the Insulin Receptor Kinase in Complex with the SH2 Domain of APS |
Heteromer Q9Z200; | 2×MN; 2×112; | ||||
Assess | ||||||
Structure of the IRS-1 PTB Domain Bound to the Juxtamembrane Region of the Insulin Receptor |
Heteromer P35568; | |||||
Assess | ||||||
human insulin receptor bound with A62 DNA aptamer | homo-2-mer | |||||
Assess | ||||||
Cryo-EM structure of long form insulin receptor (IR-B) in the apo state | homo-2-mer | |||||
Assess | ||||||
Leucine-zippered human insulin receptor ectodomain with single bound insulin - "lower" membrane-pro… | homo-2-mer | 6×NAG; | ||||
Assess | ||||||
Insulin receptor (domains 1-3) | homo-2-mer | 1×NAG; 2×NAG; 1×NAG; 2×NAG; 4×NAG; 1×NAG; 4×NAG; 8×SO4; 1×P33; 19×GOL; | ||||
Assess | ||||||
Crystal structure of the activated insulin receptor tyrosine kinase dimer | homo-2-mer | 2×ACP; 4×MG; | ||||
Assess | ||||||
PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOG | homo-2-mer | 4×MG; 2×ANP; | ||||
Assess | ||||||
Crystal structure of insulin receptor kinase domain in complex with cis-(R)-7-(3-(azetidin-1-ylmeth… | monomer | 1×60O; 1×EDO; | ||||
Assess | ||||||
Crystal structure of a catalytic-loop mutant of the insulin receptor tyrosine kinase | monomer | |||||
Assess | ||||||
Insulin receptor kinase complexed with an inhibitor | monomer | 1×GS2; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HUMAN INSULIN RECEPTOR | monomer | 2×EMC; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR | monomer | 2×MG; 1×112; | ||||
Assess | ||||||
Crystal structure of insulin receptor kinase domain in complex with an inhibitor Irfin-1 | monomer | 1×IR1; | ||||
Assess | ||||||
The Crystal structure of INSR Tyrosine Kinase in complex with the Inhibitor BI 885578 | monomer | 1×5JA; | ||||
Assess | ||||||
Insulin receptor kinase complexed with an inhibitor | monomer | 1×GS3; | ||||
Assess | ||||||
CRYSTALLOGRAPHIC STUDIES OF AN ACTIVATION LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE | monomer | 1×MG; 1×ACP; | ||||
Assess | ||||||
Crystal structure of bis-phosphorylated insulin receptor kinase domain | monomer | |||||
Assess | ||||||
Kinase domain of insulin receptor complexed with a pyrrolo pyridine inhibitor | monomer | 1×351; | ||||
Assess | ||||||
Solution structure of the transmembrane domain of the insulin receptor in micelles | monomer | |||||
Assess | ||||||
Structure of Insulin receptor's transmembrane domain | monomer | |||||
Assess |
7 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
8u4b.1.A | homo-2-mer | 0.68 | 100.00 | |||
Assess | ||||||
8vjc.1.B | monomer | 0.67 | 100.00 | |||
Assess | ||||||
8vjc.1.A | monomer | 0.66 | 100.00 | |||
Assess | ||||||
7v3p.1.B | monomer | 0.62 | 54.68 | |||
Assess | ||||||
5osm.1.A | monomer | 0.61 | 20.24 | |||
Assess | ||||||
6jk8.1.B | monomer | 0.57 | 1×NAG; | 59.59 | ||
Assess | ||||||
6jk8.1.A | monomer | 0.56 | 59.59 | |||
Assess |
8 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 8u4b.1.A | homo-2-mer | 0.69 | 100.00 | ||
Assess | ||||||
Isoform 2 | 8u4c.1.A | monomer | 0.68 | 100.00 | ||
Assess | ||||||
Isoform 2 | 8u4e.1.A | monomer | 0.66 | 100.00 | ||
Assess | ||||||
Isoform 2 | 7v3p.1.B | monomer | 0.63 | 54.68 | ||
Assess | ||||||
Isoform 2 | 7v3p.1.A | monomer | 0.61 | 54.68 | ||
Assess | ||||||
Isoform 2 | 5osm.1.A | monomer | 0.61 | 20.24 | ||
Assess | ||||||
Isoform 2 | 6jk8.1.A | monomer | 0.57 | 59.59 | ||
Assess | ||||||
Isoform 2 | 6jk8.1.B | monomer | 0.57 | 1×NAG; | 59.59 | |
Assess |